PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.\', \'Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Microbiology, Sinai Health System, Toronto, Ontario, Canada.\', \'Sinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.\', \'Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/rmv.2133
?:hasPublicationType
?:journal
  • Reviews in medical virology
is ?:pmid of
?:pmid
?:pmid
  • 33210457
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.957
?:rankingScore_hIndex
  • 82
?:title
  • Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all